Dr. Soliman Abdel Kader Fakeeh Hospital Co.

4017 Healthcare Shariah
شركة مستشفى الدكتور سليمان عبدالقادر فقيه
35.18 SAR
-0.16 (-0.45%)
Live • 12:46
Open
35.52
High
35.52
Low
35.00
Volume
0.1M
52W High
70.90
52W Low
34.36
Market Cap
8.07B SAR
P/E Ratio
26.77
Dividend Yield
0.86%
Beta
N/A

Price Chart

389 trading days
Since Jun 2024

Technical Analysis

DOWNTREND
RSI (14)
15.1
Oversold
Volatility (20D)
22.82%
Support
34.60
Resistance
35.32

Moving Averages

SMA 20
36.43
SMA 50
38.95
SMA 200
42.22
MA: Bearish RSI: Oversold

About Dr. Soliman Abdel Kader Fakeeh Hospital Co.

Dr. Soliman Abdul Kader Fakeeh Company is a prominent player in the healthcare industry of Saudi Arabia. The company specializes in hospital operation services and is renowned for providing comprehensive medical and healthcare facilities, including outpatient centers, clinical laboratories, and pharmaceutical services. Dr. Soliman Abdul Kader Fakeeh Company plays a crucial role in enhancing healthcare accessibility and quality in the region, thus addressing a fundamental societal need. The company is well-regarded for its emphasis on employing cutting-edge medical technologies and hiring highly skilled healthcare professionals to deliver premium services. This company enhances the health and well-being of its clientele by offering specialized medical treatments and preventive care, which are becoming increasingly important in the burgeoning Middle East healthcare sector. With its strategic vision and commitment to excellence, Dr. Soliman Abdul Kader Fakeeh Company holds significant market importance as it contributes to the ongoing development and transformation of regional healthcare services. As a part of the emerging healthcare landscape, it stands out for its innovative approach and dedication to patient-centered care.

Sector Healthcare
Employees 2,672
CEO Dr. Fatih Mehmet Gul
Website Visit

Performance

1 Day -0.45%
5 Days +1.68%
1 Month -9.75%
3 Months -14.40%
1 Year -48.57%
52-Week Range
34.36 70.90
2.2% of range

Key Statistics

As of 2025-12-21
Market Cap 8.07B SAR
P/E Ratio 26.77
Forward P/E 22.23
EPS (TTM) 1.3 SAR
Dividend Yield 0.86%
Beta N/A
Avg Volume 222,533

Latest News

No recent news for 4017